Regeneron and Sanofi Look for Billions From COPD Drug

[ad_1] The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. [ad_2] Source link

Gordon Moore, Intel Co-Founder and Author of Moore’s Law, Dies at 94

[ad_1] Gordon Moore, the electronics pioneer who co-founded Intel Corp. and whose groundbreaking theories defined the tempo of innovation in semiconductors, has died at the age of 94. A 1965…

Regeneron Borrows From Big Pharma Playbook to Keep Roche, Shorts at Bay

[ad_1] Eylea, the company’s top-selling blockbuster, isn’t going away soon. [ad_2] Source link

Top Companies for Employee Engagement and Development

[ad_1] Adobe heads this list from the Management Top 250 ranking, followed by Nvidia and Salesforce [ad_2] Source link

WSJ News Exclusive | Sequoia Pares Back China Tech Investments as U.S. National-Security Concerns Grow

[ad_1] WSJ News Exclusive Finance Venture-capital firm starts screening its China arm’s investments as Washington prepares to limit U.S. capital going to some Chinese tech companies [ad_2] Source link

China’s Newest Weapon to Nab Western Technology—Its Courts

[ad_1] The growing conflict between China and the U.S. extends from computer-chip factories to a suspected spy balloon over American skies. Running through it all is a struggle for technological…

GE HealthCare Makes Push Into Artificial Intelligence

[ad_1] The company is developing a software platform that helps hospitals guide care. [ad_2] Source link

Pfizer Bids Adieu to Covid Boom Years

[ad_1] Markets Heard on the Street Financial bonanza from Covid-19 is fading, putting pressure on management to deliver new avenues of growth [ad_2] Source link

Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults

[ad_1] The company said its RSV vaccine was 83.7% effective against lower-respiratory diseases caused by RSV in the study. [ad_2] Source link

Why Biotech Is Poised for a Recovery This Year

[ad_1] Markets Heard on the Street Pharma and biotech stocks moved in opposite directions last year, but fortunes are shifting [ad_2] Source link